SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-011173
Filing Date
2019-02-19
Accepted
2019-02-19 17:05:02
Documents
1
Period of Report
2019-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6492
  Complete submission text file 0001209191-19-011173.txt   7889
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Sonsini Peter W. (Reporting) CIK: 0001559807 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 19615860